Related Experiment Videos
[The state of thrombolytic therapy in acute myocardial infarct]
Insights
Intracoronary thrombolysis offers faster recanalization for acute myocardial infarction but delays limit its benefit. Early reperfusion within 3 hours is critical for improving patient outcomes and reducing mortality.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Acute myocardial infarction (AMI) treatment remains a challenge.
- Intravenous and intracoronary thrombolysis show potential but require optimization.
- Methodological limitations have hindered documented prognostic improvement.
Purpose:
- To evaluate the efficacy of thrombolytic therapy in acute myocardial infarction.
- To determine the optimal timing for reperfusion therapy.
- To discuss methods, techniques, complications, and newer agents for thrombolysis.
Summary:
- Early reperfusion (within 3 hours of ischemia onset) is crucial for improving myocardial function and reducing mortality in AMI.
- Intracoronary thrombolysis achieves faster recanalization than intravenous administration but is often delayed.
- Newer plasminogen activators offer potential advantages with less impact on coagulation.
Impact:
- Highlights the critical time window for effective thrombolytic therapy in AMI.
- Underscores the need for rapid initiation of treatment to maximize patient benefit.
- Informs clinical practice regarding thrombolysis methods and emerging therapeutic options.
Abstract:
Current experience indicates that intravenous and intracoronary thrombolysis may prove promising in improving the prognosis of acute myocardial infarction. However, because of methodological shortcomings such as insufficient numbers of patients and retarded initiation of therapy no such improvement has been documented so far. According to findings in patients and corresponding results of experimental studies, a significant improvement in myocardial function and reduction in mortality can be achieved only when reperfusion occurs within 3 hours after onset of ischaemia. With later reperfusion the results are uncertain and benefit and damage may balance each other. Recanalization of occluded coronary arteries is achieved faster and more frequently with intracoronary than with intravenous administration of streptokinase but this advantage is often offset by the loss of time before intracoronary treatment is started. Methods, technique and complications of thrombolytic therapy, as well as further management of patients are discussed. Attention is drawn to newer activators of plasminogen which are claimed to be more effective despite lesser influence on coagulation.